Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editorial staff interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Despite a wide range of medical innovations that have improved the lives of patients today, Americans do not always get the quality health care they need. As a result many health care related groups are focusing on ways to improve both inpatient outcomes and the cost effectiveness of therapies. They are relying on an approach called evidence based medicine or EBM, which aims to take knowledge obtained from current and rigorous scientific research and apply it to health care practice and delivery.

The National Pharmaceutical Council, a Reston, VA based organization supported by about 20 of the major research based pharmaceutical companies in the nation, has made EBM its primary focus. During this this podcast, The new president of NPC, Dan Leonard, discusses why EBM has become such an important issue to the Council. He also provides examples of where the NPC has already begun some initiatives in the area of EBM and describes the role of the various health care industry sectors, including pharma, in helping to generate, evaluate, and apply sound evidence based medicine.
Dan Leonard is president of the National Pharmaceutical Council (NPC), which sponsors and participates in research on the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation. NPC’s research contributes to the scientific foundation for informed discussions about health care access, coverage, appropriate use and value. Under Leonard’s leadership, NPC is expanding its focus on evidence-based medicine to support research addressing the generation, evaluation and application of evidence. In this capacity, Leonard leads NPC in bringing the pharmaceutical industry’s technical expertise and applied scientific knowledge to considerations of evidence-based medicine, comparative effectiveness reviews, evaluation and application. Prior to coming to NPC, Leonard served as executive vice president of advocacy and professional services for America’s Health Insurance Plans (AHIP), the trade association representing companies providing health insurance coverage to more than 200 million Americans. He oversaw the departments responsible for federal and state legislative affairs and strategic communications. Previously, Leonard served as AHIP’s head of public affairs and communications. Leonard is a veteran communications and media strategist with more than 20 years of experience in strategic communications, legislative management, politics and broadcast journalism. He worked as a senior vice president at the Washington public relations firms Chlopak, Leonard, Schechter and Associates and Edelman Public Relations.

  • Add a comment

  • Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »